Tag Archives: Galera Therapeutics
Galera Therapeutics (GRTX) Gets a Hold Rating from Credit Suisse
In a report released today, Evan Seigerman from Credit Suisse maintained a Hold rating on Galera Therapeutics (GRTX – Research Report), with a price target of $8.00. The company’s shares closed last Wednesday at $7.66, close to its 52-week low
